UNH Rebound Intact, 450 By Year End!
$UnitedHealth(UNH)$ rejected near 350 and pulled back toward 300, where buyers stepped in aggressively and defended the level (higher low formed). A clean break and hold above 355 would likely mark the start of a much larger leg higher, opening the door toward 400–450. As it stands, every dip continues to get bought, reinforcing UNH as a long-term accumulation name.
Big money remains involved. Institutional flows have stayed steady, with large funds treating last year’s selloff as a rare opportunity to size into a high-quality healthcare leader. That persistent bid has prevented deeper pullbacks and kept the trend constructive.
Why UnitedHealth Still Stands Out:
Largest Medicare Advantage platform with unmatched scale
Optum diversification across care, data, and pharmacy
Strong cash flows and balance sheet durability
Defensive exposure in an uncertain macro backdrop
Valuation:
Multiple valuation approaches continue to point higher. Even conservative scenarios cluster well above current price, with fair value commonly landing in the $400–$450+ range. Lots of price targets are well above 400!
My Price Target for $UNH is $450 over the next 12 months.
Trade Idea
UNH 1/16 360C above 355
Not financial advice, just my opinion.
Image
For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs.
🎉Cash Boost Account Now Supports 35,000+ Stocks & ETFs – Greater Flexibility Now
Find out more here.
Complete your first Cash Boost Account trade with a trade amount of ≥ SGD1000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.
Other helpful links:
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- AuntieAaA·01-08 00:36GoodLikeReport